Supplier profile
REGENERON SPAIN, S.L.U.
Every public-sector award we hold for this supplier, across Spain, from 1 May 2024 to 7 Oct 2026.
Awards won
17
all time
Attributed value
€10.0m
7 shared, unvalued
Buyers
14
public bodies
Active
2024–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| HOSPITAL CLINICO SAN CARLOS | 2 | €472k |
| Servicio Andaluz de Salud. Hospital Universitario de Jaén | 2 | €300k |
| Servicio Murciano de Salud - Junta de Compras | 2 | €1.9m |
| CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL | 1 | not attributable |
| Consorci Sanitari de Terrassa | 1 | not attributable |
| Gerencia del Área de Salud de Badajoz | 1 | €62k |
| HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS | 1 | €500k |
| OSAKIDETZA - Servicio Vasco de Salud - Organización Central | 1 | €5.9m |
| Servicio Andaluz de Salud. Central Provincial de Compras de Almería | 1 | €794k |
| Servicio Andaluz de Salud. Servicios Centrales | 1 | not attributable |
What they win
Awards
All 17 awards we hold
- Spain – Antineoplastic agents – Suministro sucesivo de los medicamentos de inmunoterapia oncológica para el Área de Santiago de Compostela y Barbanza ↗Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanzashared awardawarded 7 Oct 2026
- Spain – Pharmaceutical products – SUMINISTRO SUCESIVO DE LOS MEDICAMENTOS DE INMUNOTERAPIA ONCOLÓGICA PARA LOS CENTROS HOSPITALARIOS DEL ÁREA SANITARIA DE LUGO, A MARIÑA Y MONFORTE DE LEMOS. ↗Servicio Gallego de Salud - Área Sanitaria de Lugo, A Mariña y Monforte de Lemosshared awardawarded 17 Sept 2026
- Spain – Antineoplastic and immunomodulating agents – SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS con principios activos daratumumab, talquetamab, glecaprevir/pibrentasvir, epcoritamab, atogepant, rimegepant, retlecitinib y cemiplimab de varios laboratorios farmacéuticos. ↗Servicio Murciano de Salud - Junta de Comprasshared awardawarded 9 Sept 2026
- SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS con principios activos daratumumab, talquetamab, glecaprevir/pibrentasvir, epcoritamab, atogepant, rimegepant, retlecitinib y cemiplimab de varios laboratorios farmacéuticos. ↗Servicio Murciano de Salud - Junta de Compras€1.9mawarded 8 Sept 2026
- Spain – Pharmaceutical products – ALMERIA 2º CBAM CONTR 2026 0000201911_2 ↗Servicio Andaluz de Salud. Central Provincial de Compras de Almería€794kawarded 6 Aug 2026
- Spain – Pharmaceutical products – JAEN CBAM REGENERON SPAIN, S.L.U. AM 1229/2024 ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén€300kawarded 27 May 2026
- Spain – Antineoplastic agents – La contratación, mediante Acuerdo Marco con varios empresarios, del suministro sucesivo de los medicamentos de inmunoterapia oncológica para los centros hospitalarios del Servicio Gallego de Salud ↗Servicio Gallego de Saludshared awardawarded 9 May 2026
- Spain – Pharmaceutical products – A.M suministros CONTR 2025 0000519166 ↗Servicio Andaluz de Salud. Servicios Centralesshared awardawarded 16 Apr 2026
- Spain – Antineoplastic and immunomodulating agents – PNSP HUPA 163/25 ↗HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS€500kawarded 11 Mar 2026
- Spain – Pharmaceutical products – SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: CEMIPLIMAB (LIBTAYO) ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€121kawarded 5 Mar 2026
- Spain – Pharmaceutical products – FÁRMACOS EXCLUSIVOS ↗CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELLshared awardawarded 14 Nov 2025
- Spain – Various medicinal products – Adjudicación del Contrato Específico derivado del Sistema Dinámico de Adquisición del Suministro del Medicamento Exclusivo CEMIPLIMAB 350 MG INYECTABLE PERFUSIÓN VIAL para el Consorci Sanitari de Terrassa ↗Consorci Sanitari de Terrassaawarded 6 Nov 2025
- Suministro por exclusividad del fármaco CEMIPLIMAB, medicamento LIBTAYO 350 Mg Solución inyectable con destino a la Farmacia Hospitalaria del Área de Salud de Badajoz ↗Gerencia del Área de Salud de Badajoz€62kawarded 24 Sept 2025
- Spain – Pharmaceutical products – Suministro de CEMIPLIMAB 350 MG vial (LIBTAYO) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. ↗HOSPITAL CLINICO SAN CARLOS€310kawarded 17 Sept 2025
- Spain – Pharmaceutical products – Suministro de CEMIPLIMAB 350 MG vial (LIBTAYO) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid. ↗HOSPITAL CLINICO SAN CARLOS€161kawarded 17 Sept 2025
- Spain – Pharmaceutical products – Suministro de Cemiplimab (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€5.9mawarded 4 Sept 2025
- Spain – Pharmaceutical products – Suministros ( CCA. 6AX64H-) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaénshared awardawarded 1 May 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative. Profiles may take up to an hour to reflect newly collected records.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.